NCT02521493: Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
- State
- Under way
- Phase
- Phase 3
- People
- 280 taking part
- Started
- 23 Dec 2015
- Primary completion
- 30 Jun 2024
- Arms
- Arm A (standard risk)
- Results
- Posted on the registry
- 13 Aug 2015: Trial registered
- 23 Dec 2015: Trial started
- 13 Jun 2025: Trial results posted